CVRx, Inc. (NASDAQ: CVRX), a Minneapolis-based developer of neuromodulation therapies for cardiovascular diseases, has appointed John Landry as its new chief financial officer. Landry will assume the role on October 12, 2026, following Jared Oasheim’s departure, which aligns with his previously disclosed transition agreement. Oasheim has been with CVRx since 2015, guiding the company through its initial public offering in 2015 and remaining until the end of the fiscal quarter ending September 30, 2026, before stepping down.
CVRx Names John Landry as New CFO, Succeeding Oasheim
John Landry, former CFO of Nyxoah SA, will take over as chief financial officer of CVRx starting October 12, 2026, following Jared Oasheim’s transition.
PA
Priya Anand · Equities & Earnings Desk · 21 Sept 2026 · 22:50 · 1 Min. Lesezeit
Dieser Artikel wurde mit KI-Unterstützung erstellt und von einer Finances-Review-Redakteurin bearbeitet.
ADVERTISEMENT
PA
Geschrieben von
Priya Anand
Equities & Earnings Desk
Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.
Mehr von Priya Anand →
